Max International
Max International, with a valuation of $50 million, is raising funds on Issuance Express. The company uses its proven cellular enhancement technology to create clinically validated supplements. Max International is known for its glutathione supplements that defend the cells against pollution, toxins, free radicals, radiation, and heavy metals, battle oxidative stress, increase antioxidant defense, and increase energy. The company has four US patents, product approvals in 21 countries, and a global distribution network. Jonathan Flicker founded Max International in February 2023. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $5 million. The campaign proceeds will be used for marketing, inventory, and general corporate purposes.
Investment Overview
Raised: $27,716
Deal Terms
Total Commitments ($USD)
- Platform
- Issuance Express
- Start Date
- 08/14/2024
- Close Date
- 04/30/2025
$50,000
$5,000,000
$250
Equity - Preferred
Series A
RegCF
$10.00
$50,000,000
Company & Team
Company
- Year Founded
- 2023
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- High
- Capital Intensity
- Low
Financials
- Revenue -0.4% YoY
- $14,603,138
- Monthly Burn
- $753,887
-
Runway
- 1.7 months
- Gross Margin
- 61%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $17,983,442
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/30/2025 | Issuance Express | $50,000,000 | $27,716 | Equity - Preferred | Active | RegCF |